Skip to main content

Glickman Daniel R's Form 4 filing

CME Group Inc. (CME) · filed Aug 9, 2023

Accession no.
0001156375-23-000133
Filed
Aug 9, 2023
Trade date
Aug 9, 2023
Filing delay
Same day
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction. Open-market sales total $154.6K. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Glickman Daniel RCIK 0001212819Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 9, 2023Common Stock Class ASSaleDisposed−750$206.09F1−$154,567.514,658Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

On August 9, 2023, Mr. Glickman sold an aggregate of 750 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $206.00 to $206.2950. The Company maintains a record of the transaction and copies will be provided upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)